Pasithea Therapeutics Corporation

06/03/2024 | Press release | Distributed by Public on 06/03/2024 11:47

ASCO 2024 Poster Presentation: PAS-004: A novel macrocyclic MEK inhibitor inhibits cancer cell growth in vitro and tumor growth in mouse xenograft studies